Summary
Fifty-eight patients on long term conventional mainly bovine insulins have been transferred to highly purified porcine insulin preparations. There was an overall reduction of 22% in daily insulin dosage and improved diabetic control as shown by decreased blood glucose concentration. Increased concentrations of serum free insulin and falls in serum bound insulin levels were also found. There were reductions in the serum binding capacities and affinity constants on changeover from conventional to highly purified insulin due to a combination of the effects of differential conventional/purified porcine binding and the substitution of a low antigenicity insulin. However, 12 of the patients receiving higher doses of insulin experienced marked hypoglycaemic reactions immediately on insulin change-over despite initial dosage reductions of 30% and prior to any changes in antibody characteristics.
Article PDF
Similar content being viewed by others
References
Berson, S.A. Yalow, R.S.: The present status of insulin antagonists in plasma. Diabetes13, 247–259 (1964)
Lauvaux, J.P., Ooms, H.A., Christiansen, A.H.: Insulin antibodies in insulin-treated patients; A clinical trial with highly purified insulins. Excerpta Medica. International Congress Series316, 40–46 (1973)
Lithner, F.: Treatment of diabetes mellitus with monocomponent insulins. Opsucula Medica20, 249–254 (1975)
Andreani, D.: Some aspects of treatment with monocomponent (MC) and monospecies (MS) insulins. Excerpta Med. Int. Congr. Ser.316, 68–75 (1973)
Devlin, J.G., Brien, T.G.: Relationship between differential antibody binding capacity and clinical requirements of beef and pork insulin. Metabolism14, 1034–1036 (1965)
Dixon, K., Exon, P.D., Malins, J.M.: Insulin antibodies and the control of diabetes. Q. J. Med.176, 543–553 (1975)
Trinder, P.G.: Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol.22, 158–161 (1969)
Asplin, C.M., Goldie, D.J., Hartog, M.: The measurement of serum free insulin by steady-state gel filtration. Clin. Chim. Acta75, 393–399 (1977)
Albano, J.D.M., Ekins, R.P., Martiz, G., Turner, R.C.: A sensitive precise, radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol. (Kbh.)70, 487–509 (1972)
Dixon, K.: Measurement of antibodies to insulin in serum. Clin. Chem.20, 1275–1281 (1974)
Scatchard, G.: Attraction of protein for small molecules. Ann. N. Y. Acad. Sci.51, 660–672 (1949)
Baxter, R.C., Yue, D.K., Turtle, J.R.: Equilibrium studies of insulin antibodies in diabetic subjects. Clin. Chem.22, 1089–1094 (1976)
Berson, S.A., Yalow, R.S.: Quantitative aspects of the reaction between insulin and anti-insulin binding antibody J. Clin. Invest.38, 1996–2016 (1959)
Luyckx, A., Daubresse, J.C., Lefebvre, P.: L'intérêt des insulines monocomposées dans le traitement du diabete. Méd. et Hyg.32, 1–10 (1974)
Andreani, D., Lavicoli, M., Tamburrano, G., Menzinger, G.: Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Horm. Metab. Res.6, 447–454 (1974)
Devlin, J.G., Parameswaran, V.: Immunologic response to monocomponent insulin in newly diagnosed diabetic patients. J. Irish Med. Assoc.68, 301–305 (1975)
Czyzyk, A., Lawecki, J., Rogala, H., Miedzińska, E., Popik-Hankiewic, A.: Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin. Diabetologia10, 233–236 (1974)
Bruni, B., D'Alberto, M., Osenda, M., Ricci, C., Turco, G.L.: Clinical trial with monocomponent lente insulins. Diabetologia9, 492–498 (1973)
Yue, D.K., Turtle, J.R.: Antigenicity of “monocomponent” pork insulin in diabetic subjects. Diabetes24, 625–632 (1975)
Oakley, N.W.: Effect of “fractionated” insulins on total plasma insulin binding capacity and insulin requirement in severe diabetes. Lancet1976 I, 994–996
Tchobroutsky, G.: How to achieve better diabetic control? Studies with insulin three times a day. Excerpta Med. Int. Congr. Ser.312, 667–679 (1974)
Logie, A.W., Stowers, J.M.: Hazards of monocomponent insulin. Br. Med. J.1976 I, 879
Evans, D.R., Smith, C.S.: Hazards of monocomponent insulin. Br. Med. J. 1976I, 1146
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Asplin, C.M., Hartog, M. & Goldie, D.J. Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin. Diabetologia 14, 99–105 (1978). https://doi.org/10.1007/BF01263447
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01263447